Blog
EQS-News: Endor AG: Matthias Kosch succeeds Andras Semsey as new CFO
EQS-News: Endor AG: Matthias Kosch succeeds Andras Semsey as new CFO
EQS-Adhoc: PANTAFLIX AG resolves to issue a 3% corporate convertible bond 2023/2026
EQS-Adhoc: PANTAFLIX AG resolves to issue a 3% corporate convertible bond 2023/2026
EQS-Adhoc: Endor AG: Change in the Management Board
EQS-Adhoc: Endor AG: Change in the Management Board
EQS-News: niiio finance group AG: niiio finance group significantly increases revenue and EBITDA margin in the first half of 2023
EQS-News: niiio finance group AG: niiio finance group significantly increases revenue and EBITDA margin in the first half of 2023
EQS-Adhoc: MBH Corporation Plc Announces H1 2023 Financial Results
EQS-Adhoc: MBH Corporation Plc Announces H1 2023 Financial Results
Nordea Bank Abp: Transaction in Own Shares
Nordea Bank Abp: Transaction in Own Shares
EQS-News: SYNLAB AG: SYNLAB enters into investment agreement relating to a public acquisition offer by Cinven
EQS-News: SYNLAB AG: SYNLAB enters into investment agreement relating to a public acquisition offer by Cinven
EQS-Adhoc: SYNLAB AG: Cinven announces public acquisition offer | Conclusion of Investment Agreement
EQS-Adhoc: SYNLAB AG: Cinven announces public acquisition offer | Conclusion of Investment Agreement
EQS-News: Klöckner & Co reorganizes responsibilities within the Management Board
EQS-News: Klöckner & Co reorganizes responsibilities within the Management Board
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Private placement of secured notes and investment grade credit rating
Private placement of secured notes and investment grade credit rating
EQS-News: exceet Group SCA: Financial Results First Half-Year 2023
EQS-News: exceet Group SCA: Financial Results First Half-Year 2023
EQS-News: Formycon and Fresenius Kabi announce European Medicines Agency Submission Acceptance of the Marketing Authorization Application for FYB202, an Ustekinumab Biosimilar Candidate
EQS-News: Formycon and Fresenius Kabi announce European Medicines Agency Submission Acceptance of the Marketing Authorization Application for FYB202, an Ustekinumab Biosimilar Candidate
Spexis provides business update and announces financial results for the first half of 2023
Spexis provides business update and announces financial results for the first half of 2023
Ørsted completes 200 MW wind farm in Kansas
Ørsted completes 200 MW wind farm in Kansas
ESG Report shows status quo and outlines path for future sustainability improvements Media Release Zurich, September 29, 2023
ESG Report shows status quo and outlines path for future sustainability improvements
Media Release
Zurich, September 29, 2023
Thalassa Holdings Ltd: Amendment to Articles of Association
Thalassa Holdings Ltd: Amendment to Articles of Association
EQS-News: PANTAFLIX AG with production-driven revenue growth in the first half of 2023
EQS-News: PANTAFLIX AG with production-driven revenue growth in the first half of 2023
Renewi plc: Further response to possible offer announcement by Macquarie Asset Management (“Macquarie”)
Renewi plc: Further response to possible offer announcement by Macquarie Asset Management (“Macquarie”)
IGEA Pharma N.V.: Convening notice and Agenda “Annual Shareholder Meeting” IGEA Pharma N.V.
IGEA Pharma N.V.: Convening notice and Agenda “Annual Shareholder Meeting” IGEA Pharma N.V.
New Capital Return Policy decided: Commerzbank plans to increase shareholder participation in company’s success
New Capital Return Policy decided: Commerzbank plans to increase shareholder participation in company’s success
Commerzbank has decided on new Capital Return Policy
Commerzbank has decided on new Capital Return Policy
EQS-News: New Capital Return Policy decided: Commerzbank plans to increase shareholder participation in company’s success
EQS-News: New Capital Return Policy decided: Commerzbank plans to increase shareholder participation in company’s success
EQS-Adhoc: Commerzbank has decided on new Capital Return Policy
EQS-Adhoc: Commerzbank has decided on new Capital Return Policy
Kaufman & Broad SA: FITCH RATING CONFIRMS KAUFMAN & BROAD'S RATING
Kaufman & Broad SA: FITCH RATING CONFIRMS KAUFMAN & BROAD'S RATING


